SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-22-010269
Filing Date
2022-04-29
Accepted
2022-04-29 16:31:17
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A plxp20211231_10ka.htm   iXBRL 10-K/A 395404
2 EXHIBIT 31.3 ex_360386.htm EX-31.3 7431
3 EXHIBIT 31.4 ex_360387.htm EX-31.4 6062
  Complete submission text file 0001437749-22-010269.txt   648285

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA noticker-20211231.xsd EX-101.SCH 3633
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20211231_def.xml EX-101.DEF 17175
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20211231_lab.xml EX-101.LAB 23278
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20211231_pre.xml EX-101.PRE 18156
9 EXTRACTED XBRL INSTANCE DOCUMENT plxp20211231_10ka_htm.xml XML 6280
Mailing Address 9 FISHERS LANE SUITE E SPARTA NJ 07871
Business Address 9 FISHERS LANE SUITE E SPARTA NJ 07871 (713) 842-1249
PLx Pharma Inc. (Filer) CIK: 0001497504 (see all company filings)

IRS No.: 271707962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36351 | Film No.: 22876172
SIC: 2834 Pharmaceutical Preparations